Endo Looks To Join Genzyme-Impax Renagel Battle
Endo Pharmaceuticals Inc. has asked a court for permission to intervene in Genzyme Corp.'s Renagel patent infringement case against Impax Laboratories Inc., arguing that Impax challenged a second patent's validity solely...To view the full article, register now.
Already a subscriber? Click here to view full article